Emily Bodner
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Emily Bodner
Emily Bodner is recorded as Analyst at H.C. Wainwright. Emily Bodner has spoken on 6 earnings calls and 6 other investor events across 8 companies, most recently for Geron Corp on September 15, 2026. Those appearances were for Tg Therapeutics, Inc. (TGTX), Artiva Biotherapeutics, Inc. (ARTV), Autolus Therapeutics plc (AUTL), Agios Pharmaceuticals, Inc. (AGIO), Geron Corp (GERN) and 3 other companies. The companies whose calls Emily Bodner spoke on are classified in the Healthcare sector.
Emily Bodner on recent calls
“I'll be doing a fireside chat with Harut Sumerjian, Chief Executive Officer, and Joseph Ede, Chief Medical Officer of Geron. Maybe for those who are newer to the Geron story, if you could start by walking us through your lead asset, Immatelstat, or brand name Ritello, which is approved for low-risk MDS.”
“Good afternoon, everyone, and thank you for coming to the H.C. Wainwright 28th annual Global Investment Conference. My name is Emily Bodner, and I'm an equity research analyst at H.C. Wainwright.”
“Good afternoon, everyone, and thank you for coming to the H.C. Wainwright 28th Annual Global Investment Conference. My name is Emily Bodner, and I'm an equity research analyst at H.C. Wainwright.”
“Have you commented on how many sites you're expecting to be included in the prize study? I'm just kind of curious on if timing for enrollment cadence could be similar to Safeguard.”
“Good afternoon, everyone, and thank you for joining the H.C. Wainwright fourth annual virtual cell therapy conference. My name is Emily Bodner, and I'm an equity research analyst at H.C. Wainwright.”
Affiliation history
-
H.C. Wainwright
Analyst
Source not stated
Current
Company network
Geron Corp
GERN
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-15
View calls and events
NovoCure Ltd
NVCR
Medical Devices · Healthcare
1 appearance
Latest appearance 2026-04-30
View calls and events